Muiño-Mosquera, L., Cervi, E., De Groote, K., Dewals, W., Fejzic, Z., Kazamia, K., Mathur, S., Milleron, O., Mir, T. S., Nielsen, D. G., Odermarsky, M., Sabate-Rotes, A., van der Hulst, A., Valenzuela, I. & Jondeau, G. (2024). Management of aortic disease in children with FBN1-related Marfan syndrome: A joint statement from the paediatric subgroup of the European Reference Network of Vascular Diseases (VASCERN, Heritable Thoracic Aortic Disease working group) and the Association for European Paediatric and Congenital Cardiology (AEPC). European Heart Journal, 45(39), 4156-4169. https://doi.org/10.1093/eurheartj/ehae526

Grahammer, F., Dumoulin, B., Gulieva, R. E., Wu, H., Xu, Y., Sulaimanov, N., Arnold, F., Sandner, L., Cordts, T., Todkar, A., Moulin, P., Reichardt, W., Puelles, V. G., Kramann, R., Freedman, B. S., Busch, H., Boerries, M., Walz, G. & Huber, T. B. (2024). Cyclin-dependent kinase 4 drives cystic kidney disease in the absence of mTORC1 signaling activity. Kidney International, 106(5), 856-869. https://doi.org/10.1016/j.kint.2024.08.021

Chandran, A., van Harten, M., Singh, D., Vilaseca, J., Patasius, A., Tupikowski, K., Amorín, Á. G., Galvin, D., López, H., Salazar, J. P., Arnau, A., Cuberas, G., Miksiene, G., Hodyra-Stefaniak, K., Litwin, M., Krynicka-Duszyńska, M., Zawadzki, P., Maciejczyk, A., Horgan, G. ... the PRAISE-U Consortium (2024). Risk-stratified Approach to Implementing Population-based Prostate Cancer Screening in Five Pilot Sites in the European Union: A Protocol for the PRAISE-U Project. European Urology Open Science, 70, 8-17. https://doi.org/10.1016/j.euros.2024.09.003

Adelborg, K., Bjørnshave, K., Mortensen, M. B., Espeseth, E., Wolff, A. & Løfgren, B. (2014). A randomised crossover comparison of mouth-to-face-shield ventilation and mouth-to-pocket-mask ventilation by surf lifeguards in a manikin. Anaesthesia, 69(7), 712-716. https://doi.org/10.1111/anae.12669

Luppi, F., Manfredi, A., Faverio, P., Franco, G., Salvarani, C., Bendstrup, E. & Sebastiani, M. (2024). Treatment of acute exacerbation in interstitial lung disease secondary to autoimmune rheumatic diseases: More questions than answers. Autoimmunity Reviews, 23(12), Article 103668. https://doi.org/10.1016/j.autrev.2024.103668

Vaz, J., Willemse, J. & Jepsen, P. (2024). Addressing the impact of stigma in liver diseases: A call for proper language and responsibility allocation. Journal of Hepatology, 81(5), e221-e222. https://doi.org/10.1016/j.jhep.2024.08.004

Thomsen, M. S., Alsner, J., Lutz, C. M., Berg, M., Jensen, I., Lorenzen, E. L., Nielsen, H. M., Jakobsen, E. H., Stenbygaard, L., Nielsen, M. H., Jensen, M. B., Overgaard, J. & Offersen, B. V. (2024). Breast induration and irradiated volume in the DBCG HYPO trial: The impact of age, smoking, and boost. Radiotherapy and Oncology, 201, Article 110574. https://doi.org/10.1016/j.radonc.2024.110574

the Surveillance, Risk Assessment, Policy Sub-group of the ISBT Transfusion Transmitted Infectious Diseases Working Party (2024). The International Society of Blood Transfusion (ISBT) Public Health Research Toolkit: A report from the Surveillance, Risk Assessment and Policy Sub-group of the ISBT Transfusion Transmitted Infectious Diseases Working Party. Vox Sanguinis, 119(10), 1122-1125. https://doi.org/10.1111/vox.13713

Jurlander, R. S., Guldbrandt, L. M., Holmstroem, R. B., Madsen, K., Donia, M., Haslund, C. A., Schmidt, H., Bastholt, L., Ruhlmann, C. H., Svane, I. M. & Ellebaek, E. (2024). Immune-related adverse events in a nationwide cohort of real-world melanoma patients treated with adjuvant anti-PD1 – Seasonal variation and association with outcome. European Journal of Cancer, 212, Article 115053. https://doi.org/10.1016/j.ejca.2024.115053

Alviggi, C., Humaidan, P., Fischer, R., Conforti, A., Dahan, M. H., Marca, A. L., Orvieto, R., Polyzos, N. P., Roque, M., Sunkara, S. K., Ubaldi, F. M., Vuong, L., Yarali, H., D’Hooghe, T., Longobardi, S. & Esteves, S. C. (2024). Patients with low prognosis in ART: a Delphi consensus to identify potential clinical implications and measure the impact of POSEIDON criteria. Reproductive Biology and Endocrinology, 22(1), Article 122. https://doi.org/10.1186/s12958-024-01291-x